C18.6 Malignant neoplasm, descending colon - analogs
| Description «C18.6 Malignant neoplasm, descending colon» | ||||||
|
||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 40% Compare C18.2 Malignant neoplasm, ascending colon
- 40% Compare C18.4 Malignant neoplasm, transverse colon
- 40% Compare C18 Malignant neoplasm of colon
- 24% Compare C18.7 Malignant neoplasm, sigmoid colon
- 24% Compare C19 Malignant neoplasm of rectosigmoid junction
- 24% Compare C21.1 Malignant neoplasm, anal canal
- 24% Compare C20 Malignant neoplasm of rectum
- 24% Compare C21 Malignant neoplasm of anus and anal canal
- 24% Compare C21.8 Malignant neoplasm, overlapping lesion of rectum, anus and anal canal
- 23% Compare D01.4 Carcinoma in situ, other and unspecified parts of intestine
- 20% Compare D12 Benign neoplasm of colon, rectum, anus and anal canal
- 20% Compare C17.9 Malignant neoplasm, small intestine, unspecified
- 20% Compare C78.5 Secondary malignant neoplasm of large intestine and rectum
- 20% Compare C21.0 Malignant neoplasm, anus, unspecified
- 15% Compare D12.6 Benign neoplasm, colon, unspecified
- 15% Compare C78.4 Secondary malignant neoplasm of small intestine
- 10% Compare C53.1 Malignant neoplasm, exocervix
- 10% Compare C10 Malignant neoplasm of oropharynx
- 10% Compare D37.6 Neoplasm of uncertain or unknown behaviour, liver, gallbladder and bile ducts
- 10% Compare D14.3 Benign neoplasm, bronchus and lung
- 10% Compare C78.7 Secondary malignant neoplasm of liver and intrahepatic bile duct
- 10% Compare C78.0 Secondary malignant neoplasm of lung
- 10% Compare C54.8 Malignant neoplasm, overlapping lesion of corpus uteri
- 10% Compare C40.2 Malignant neoplasm, long bones of lower limb
- 10% Compare C92.1 Chronic myeloid leukaemia [CML], BCR/ABL-positive
- 10% Compare C22 Malignant neoplasm of liver and intrahepatic bile ducts
- 10% Compare C40.0 Malignant neoplasm, scapula and long bones of upper limb
- 10% Compare C53.8 Malignant neoplasm, overlapping lesion of cervix uteri
- 10% Compare C52 Malignant neoplasm of vagina
- 10% Compare C40.3 Malignant neoplasm, short bones of lower limb
- 10% Compare C44.1 Malignant neoplasm, skin of eyelid, including canthus
- 10% Compare C62 Malignant neoplasm of testis
- 10% Compare C54 Malignant neoplasm of corpus uteri
- 10% Compare C40.1 Malignant neoplasm, short bones of upper limb
- 10% Compare C62.1 Malignant neoplasm, descended testis
- 10% Compare C41.1 Malignant neoplasm, mandible
- 10% Compare C53.9 Malignant neoplasm, cervix uteri, unspecified
- 10% Compare D00 Carcinoma in situ of oral cavity, oesophagus and stomach
- 10% Compare C53 Malignant neoplasm of cervix uteri
- 10% Compare D04 Carcinoma in situ of skin
- 10% Compare C15.0 Malignant neoplasm, cervical part of oesophagus
- 10% Compare C54.3 Malignant neoplasm, fundus uteri
- 10% Compare C08.0 Malignant neoplasm, submandibular gland
- 10% Compare C62.9 Malignant neoplasm, testis, unspecified
- 10% Compare C77.9 Secondary and unspecified malignant neoplasm, lymph node, unspecified
- 10% Compare C79.2 Secondary malignant neoplasm of skin
- 10% Compare C77.8 Secondary and unspecified malignant neoplasm, lymph nodes of multiple regions
- 10% Compare C78.1 Secondary malignant neoplasm of mediastinum
- 10% Compare Z54.1 Convalescence following radiotherapy
- 10% Compare C41.8 Malignant neoplasm, overlapping lesion of bone and articular cartilage
Learn more about the selection of analogues
▶
- Medical online service designed to help in differential diagnostics.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.